Darren Jolliffe

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

Richard B. Pollard, Jürgen K. Rockstroh, Giuseppe Pantaleo et al. · The Lancet Infectious Diseases · 2014 · 107 citations · Full text

A case for preART-adjusted endpoints in HIV therapeutic vaccine trials

Yunda Huang, Lily Zhang, Darren Jolliffe et al. · Vaccine · 2016 · 11 citations

Vaccination, Preventive Medicine, Treatment And Prevention +8

Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption

Jürgen K. Rockstroh, David M. Asmuth, Giuseppe Pantaleo et al. · PLoS ONE · 2019 · 11 citations · Full text

Postvaccination C-Reactive Protein and C5/gp41 ^732–744 Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x

Yunda Huang, Lily Zhang, Darren Jolliffe et al. · AIDS Research and Human Retroviruses · 2018 · 10 citations